Clinical Trial Update: A Study of Peripheral Blood Progenitor Cells Mobilisation (PBPC) With VTP195183 Plus Granulocyte-Colony Stimulating Factor (G-CSF) Compared to Mobilisation With G-CSF Alone [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial compares mobilisation of peripheral blood progenitor cells using VTP195183 plus G-CSF versus G-CSF alone in patients with multiple myeloma or …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Multiple Myeloma

Drugs mentioned

• Filgrastim (filgrastim)
• VTP195183

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Multiple Myeloma, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED